Accord Healthcare Inc, the US arm of Intas Pharmaceuticals, is recalling over 46,000 bottles of Hydrochlorothiazide tablets manufactured by the Ahmedabad-based firm, on account of labelling mix-up, USFDA said.
Hydrochlorothiazide tablets belong to a class of drugs known as diuretics and are used for treatment of high blood pressure and edema.
Accord Healthcare is recalling 46,632 bottles of Hydrochlorothiazide tablets USP in the strength of 12.5 mg, the Enforcement Report by United States Food and Drug Administration (USFDA) said.
The reason for the recall is “Labelling: label mix-up: customer complaint that a sealed bottle labelled as Hydrochlorothiazide tablets USP 12.5 mg contained only Spironolactone tablets USP 25 mg,” it added.
The voluntary nationwide recall in the US and Puerto Rico has not been classified yet, the report said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.